Icon

ANZEMET (nda020623)- (50MG,100MG)

DOLASETRON MESYLATE VALIDUS PHARMS
50MG,100MG
No No
2011-Jul-02 Expired
None None
None No
ANZEMET is indicated for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy, including initial and repeat courses in adults and children 2 years and older.
0 0 0
Total Other Developers None
Drugs with Suitability No
50MG ** ** - - -
100MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.